[Answered]: Patient: Mr

Patient: Mr. J, 51‐year‐old male Chief Complaint: “Frequent urination and getting winded at work.” HPI: 3 months of progressive polyuria, polydipsia, and nocturia x2–3/night. Reports 10 lb unintentional weight loss over 2 months, blurred vision intermittently, and increased fatigue. Notes substernal burning with spicy foods and late meals, relieved by antacids; uncertain if this differs from occasional tightness when hurrying up stairs (resolves in 5 minutes of rest). Denies syncope, radiation, or diaphoresis. Developed morning cough with occasional wheeze during seasonal changes; no hemoptysis. No fevers. Past Medical History: Borderline hypertension; dyslipidemia (untreated). No known ASCVD. Childhood eczema. Medications: None prescribed; OTC antacids PRN; ibuprofen PRN. Allergies: NKDA. Family History: Father MI at 58; mother T2DM. Social: Forklift operator on evening shift; smokes 10–12 cigarettes/day (≈18 pack‐years); alcohol 2–3 beers/week; diet high in fast food; limited exercise. Lives with spouse. Financial strain present. ROS (salient): +polyuria, +polydipsia, +nocturia, +blurred vision, +DOE with exertion, +morning cough/wheeze; –orthopnea/PND, –LE edema, –black/tarry stools, –fever/chills, –weight gain. Vitals: BP 148/92 (repeat 146/90), HR 86, RR 18, Temp 98.6°F, SpO2 96% RA, BMI 31 kg/m2, waist 41 in. Physical Exam Highlights: General well appearing, central adiposity. HEENT benign. Lungs: mild end‐expiratory wheeze R>L; no crackles. Cardiac: RRR, no M/R/G. Abdomen: soft, NT/ND, no HSM. Extremities: no edema. Neuro: monofilament decreased at hallux bilaterally. Skin: dry heels; no ulcers. Point‐of‐Care/Initial Data: Random plasma glucose 262 mg/dL; A1C 9.6%; CMP: Cr 1.0 (eGFR 78), K 4.3; LFTs WNL; Lipids: TC 236, LDL‐C 154, HDL‐C 36, TG 240 mg/dL; HS‐CRP not done; TSH 2.0. UA: trace protein, negative ketones; UACR 37 mg/g. EKG: NSR, no acute ischemic changes. Problem Representation: 52M with tobacco use, obesity, probable new T2DM with hyperglycemia and microalbuminuria, atherogenic dyslipidemia, stage‐2 HTN range, GERD symptoms vs exertional chest tightness, and intermittent wheeze—multisystem risks involving endocrine, cardiovascular, and pulmonary systems.